VERADIGM INC (MDRX)
(Delayed Data from OTC)
$7.95 USD
-0.08 (-1.00%)
Updated Apr 25, 2024 04:00 PM ET
3-Hold of 5 3
A Value D Growth F Momentum C VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
MDRX 7.95 -0.08(-1.00%)
Will MDRX be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for MDRX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for MDRX
Veradigm (MDRX) to Acquire AI Service Provider ScienceIO
Veradigm (MDRX) & MedAllies Partner for Better Care Decisions
MDRX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Veradigm's (MDRX) Acquires Koha Health to Solidify Market Presence
Braze, Inc. (BRZE) Reports Q3 Loss, Tops Revenue Estimates
Veradigm's (MDRX) New Offering to Enhance Patient Engagement
Other News for MDRX
Teramind Announces Formation of Insider Risk Executive Advisory Board
Veradigm Network Solution Practice Fusion EHR Receives Top Ambulatory Rankings
Veradigm announces strategic collaboration with Vim
Veradigm just downgraded at Deutsche Bank, here's why
Veradigm’s Challenging Outlook: Hold Rating Justified Amid Revenue Growth, Margin Pressures, and Audit Concerns